Alan S Coates - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Alan S Coates

Showing results (61-70 of 106) with videos related to

Pageof 11

Sort By:

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012

Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trialMarianne Ewertz, Kathryn P Gray, Meredith M Regan, et al.

Journal of the National Cancer Institute|November 2, 2006

Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assaysMeredith M Regan, Giuseppe Viale, Mauro G Mastropasqua, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2017

Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 StudySigne Borgquist, Anita Giobbie-Hurder, Thomas P Ahern, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005

Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Cancer Study Group Trial VIGünther Gruber, Marco Bonetti, M Laura Nasi, et al.

Journal of the National Cancer Institute|January 31, 2008

Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancerGiuseppe Viale, Meredith M Regan, Mauro G Mastropasqua, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2018

Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II TrialSilvia Dellapasqua, Kathryn P Gray, Elisabetta Munzone, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2007

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98Giuseppe Viale, Meredith M Regan, Eugenio Maiorano, et al.

Breast (Edinburgh, Scotland)|March 5, 2013

Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trialDiana Crivellari, Kathryn P Gray, Silvia Dellapasqua, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2007

The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancerPer Karlsson, Bernard F Cole, Karen N Price, et al.

Breast Cancer Research : BCR|November 10, 2016

Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trialHarriet Johansson, Kathryn P Gray, Olivia Pagani, et al.

Pageof 11

Search research articles

Showing results (61-70 of 106) with videos related to

Sort By:

Pageof 11

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012

Journal of the National Cancer Institute|November 2, 2006

Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assaysMeredith M Regan, Giuseppe Viale, Mauro G Mastropasqua, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2017

Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 StudySigne Borgquist, Anita Giobbie-Hurder, Thomas P Ahern, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005

Journal of the National Cancer Institute|January 31, 2008

Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancerGiuseppe Viale, Meredith M Regan, Mauro G Mastropasqua, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2018

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2007

Breast (Edinburgh, Scotland)|March 5, 2013

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2007

The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancerPer Karlsson, Bernard F Cole, Karen N Price, et al.

Breast Cancer Research : BCR|November 10, 2016

Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trialHarriet Johansson, Kathryn P Gray, Olivia Pagani, et al.

Pageof 11